Literature DB >> 18754735

Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection.

Duk-hee Lee1, Koo Young Jung, Yoon-Hee Choi.   

Abstract

Central venous catheter-related bloodstream infection is clinically important because of its high mortality rate. This prospective study shows by multivariate analysis that the use of maximal sterile barrier precautions (odds ratio, 5.205 [95% confidence interval, 0.015-1.136]; P=.023) and the use of antimicrobial-coated catheters (odds ratio, 5.269 [95% confidence interval, 0.073-0.814]; P=.022) are independent factors associated with a lowered risk of acquiring a central venous catheter-related bloodstream infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754735     DOI: 10.1086/590356

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study.

Authors:  Hyun Jung Kim; Jina Yun; Han Jo Kim; Kyoung Ha Kim; Se Hyung Kim; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Kyu Taek Lee; Seong Kyu Park; Jong-Ho Won; Hee Sook Park; Dae Sik Hong
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

2.  Reversal of intestinal failure-associated liver disease (IFALD): emphasis on its multifactorial nature.

Authors:  Christian Hvas; Kamelia Kodjabashia; Emma Nixon; Stephen Hayes; Kirstine Farrer; Arun Abraham; Simon Lal
Journal:  Frontline Gastroenterol       Date:  2015-04-09

3.  Positive effect of care bundles on patients with central venous catheter insertions at a tertiary hospital in Beijing, China.

Authors:  Yuling Sun; Zhongying Bao; Yang Guo; Xiaodong Yuan
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

4.  Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.

Authors:  Niccolò Buetti; Jonas Marschall; Marci Drees; Mohamad G Fakih; Lynn Hadaway; Lisa L Maragakis; Elizabeth Monsees; Shannon Novosad; Naomi P O'Grady; Mark E Rupp; Joshua Wolf; Deborah Yokoe; Leonard A Mermel
Journal:  Infect Control Hosp Epidemiol       Date:  2022-04-19       Impact factor: 6.520

Review 5.  [Korean Clinical Practice Guidelines for Adverse Reactions to Intravenous Iodinate and MRI-Gadolinium Contrast Agents: Revised Clinical Consensus and Recommendations (3rd Edition, 2022)].

Authors:  Se Won Oh; So Young Park; Hwan Seok Yong; Young Hun Choi; Min Jae Cha; Tae Bum Kim; Ji Hyang Lee; Sae Hoon Kim; Jae Hyun Lee; Gyu Young Hur; Jae Yeon Hwang; Sejoong Kim; Hyo Sang Kim; Ji Young Ryu; Miyoung Choi; Chi-Hoon Choi
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-03-28

6.  Implementation of central line-associated bloodstream infection prevention bundles in a surgical intensive care unit using peer tutoring.

Authors:  Sang-Won Park; Suhui Ko; Hye-Sun An; Ji Hwan Bang; Woo-Young Chung
Journal:  Antimicrob Resist Infect Control       Date:  2017-10-02       Impact factor: 4.887

7.  Effect of Central Line Bundle Compliance on Central Line-Associated Bloodstream Infections.

Authors:  Kyoung Hwa Lee; Nan Hyoung Cho; Su Jin Jeong; Mi Na Kim; Sang Hoon Han; Young Goo Song
Journal:  Yonsei Med J       Date:  2018-05       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.